Polio eradication action with informed and engaged societies
After nearly 28 years, The Communication Initiative (The CI) Global is entering a new chapter. Following a period of transition, the global website has been transferred to the University of the Witwatersrand (Wits) in South Africa, where it will be administered by the Social and Behaviour Change Communication Division. Wits' commitment to social change and justice makes it a trusted steward for The CI's legacy and future.
 
Co-founder Victoria Martin is pleased to see this work continue under Wits' leadership. Victoria knows that co-founder Warren Feek (1953–2024) would have felt deep pride in The CI Global's Africa-led direction.
 
We honour the team and partners who sustained The CI for decades. Meanwhile, La Iniciativa de Comunicación (CILA) continues independently at cila.comminitcila.com and is linked with The CI Global site.
Time to read
1 minute
Read so far

Vaccine Hesitancy, Refusal and Access Barriers: The Need for Clarity in Terminology

0 comments
Affiliation

Institute of Child Health (Bedford); University of Western Australia (Attwell); Murdoch Children's Research Institute (Danchin); University of Adelaide and Women's and Children's Health Network (Marshall); North Coast Public Health Unit (Corben); University of Sydney (Leask)

Date
Summary

"There is a need to develop and evaluate solutions tailored to the very real challenges of vaccine hesitancy (related to acceptance)..."

The term 'vaccine hesitancy' is used by some experts and commentators to explain all partial or non-immunisation. The authors of this article propose that more precision in the term is needed; only with clear terminology, they argue, can we begin to understand where the problem lies, measure it accurately, and develop appropriate interventions.

In public commentary about vaccination coverage, confusion can arise around: (i) 'Vaccine hesitancy' is represented as a behaviour, even though it is a psychological state; (ii) the label 'hesitancy' is applied to non-vaccination broadly, when some non-vaccinators are forthright in their refusal, and may never have been hesitant; and (iii) 'hesitancy' is used inaccurately as the explanation for under-vaccination in a population when the causes are related to pragmatics, competing priorities, access, or the failure of services or policies.

The authors critically examine the oft-cited World Health Organization (WHO) Strategic Advisory Group of Experts on Immunization (SAGE) definition of vaccine hesitancy, which cites factors such as confidence (do not trust vaccine or provider), complacency (do not perceive a need for a vaccine, do not value vaccination), and convenience (do not have full access to vaccines due to issues around physical availability, geographical accessibility, or the ability to understand because of language or health literacy). The authors contend that adding the concept of 'convenience' to a definition of hesitancy is problematic, and the problem is compounded by the imprecision in the definition of convenience used. They observe that it bundles together concepts relating to individuals' decisions (selecting out or refusing vaccines) with individual and system-level factors that may contribute to difficulties accessing vaccines. In short, the SAGE definition perpetuates terminological imprecision, in their estimation.

The term 'vaccine hesitancy', they assert, should only be applied to those parents whose deliberations demonstrate something akin to indecision. Decisional conflict is an internationally accepted construct with a validated scale where certain scores correlate with action. They suggest under-vaccinated as the overarching term capturing those who are unvaccinated or partially vaccinated for any reason; vaccine uptake is affected by both acceptance and the logistical or opportunity-related factors. Reasons for under-vaccination could then be further expanded into a set of constructs with good content and construct validity. Each needs development of different and tailored interventions to improve uptake.

Source

Vaccine, Volume 36, Issue 44, 22 October 2018, Pages 6556-6558. http://dx.doi.org/10.1016/j.vaccine.2017.08.004. Image credit: alamy